ResMed accelerated release of ventilator telemonitoring platform to enable safer, more efficient patient care
On May 5, 2020, ResMed launched cloud-based remote monitoring software for ventilators and Lumis bilevel devices across Europe,…
-
-
Agriculture | Biotechnology | COVID-19 | Diagnostics | Infectious Disease | USDA | Vaccine
Tyson Foods Fresh Meats resumed Waterloo, Iowa operations
On May 5, 2020, Tyson Foods announced resumption of limited production at its Waterloo, Iowa facility May 7….
-
Innovation Pharma announced the next phase of Brilacidin Coronavirus testing begun
On May 5, 2020, Innovation Pharma reported it had executed executed a Material Transfer Agreement (MTA) with a…
-
SHERLOCK-based one-step test provided rapid and sensitive COVID-19 detection
On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
-
LabCorp announced availability of COVID-19 antibody test
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
-
Vir and Alnylam identified RNAi therapeutic development candidate, VIR-2703 (ALN-COV), targeting SARS-CoV-2 for treatment of COVID-19
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
-
Anixa Biosciences and OntoChem announced discovery of first Covid-19 therapeutic candidate
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
-
Cerus announced FDA approval for INTERCEPT Blood System for plasma with alternate plastic disposable kits
On May 4, 2020, Cerus announced U.S. Food and Drug Administration (FDA) regulatory approval for manufacture of INTERCEPT…
-
Eli Lilly and Junshi Biosciences to co-develop antibody therapies for pevention and treatment of COVID-19
On May 4, 2020, Junshi Biosciences and Eli Lilly announced they have entered into an agreement to co-develop therapeutic…
-
Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access program
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
-
Arcturus Therapeutics and Catalent announced partnership to manufacture mRNA-Based COVID-19 vaccine
On May 4, 2020, Arcturus Therapeutics and Catalent announced a partnership to support the expected manufacture of Arcturus’…
-
DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 test
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
-
NIH study to determine incidence of novel Coronavirus infection in US children began
On May 4, 2020, a National Institutes of Health (NIH) study to help determine the rate of novel…
-
Biotechnology | COVID-19 | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics
USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
-
BIOFIRE respiratory panel 21 (RP21) with SARS-CoV-2 obtained FDA Emergency Use Authorization
On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Pharmaceutical | Therapeutics
Government of Canada Investing in global race to find a treatment for COVID-19
On May 3, 2020, the Government of Canada announced it was investing in projects that support the global…
-
Roche’s COVID-19 antibody test received FDA Emergency Use Authorization and is available in markets accepting the CE mark
On May 2, 2020, Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency…
-
Gilead announced investigational antiviral remdesivir received FDA Emergency Use Authorization for treatment of COVID-19
On May 1, 2020, Gilead announced that the U.S. Food and Drug Administration (FDA) has granted emergency use…
-
Timing of immune response to COVID-19 may contribute to disease severity
On May 1, 2020, a new University of Southern California (USC) study suggests that temporarily suppressing the body’s immune…
-
US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
-
FDA approved DARZALEX FASPRO, a new subcutaneous formulation of Daratumumab in treatment of patients with Multiple Myeloma
On May 1, 2020, the Food and Drug Administration (FDA) approved daratumumab and hyaluronidase-fihj (DARZALEX FASPRO, Janssen Biotech.)…
-
Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
-
Cancer patients face high mortality from COVID-19
On May 1, 2020, people with cancer who develop COVID-19 are much more likely to die from the…
-
XBiotech identified ‘super bloods’ for development of True Human COVID-19 therapy
On May 1, 2020, XBiotech announced that human immune donors have now been identified that can support the Company’s…
-
Mateon announced peer reviewed publication on its R&D effort against COVID-19
On Apr. 30, 2020, Mateon Therapeutics report several peer-reviewed publications derived from its R&D effort against COVID-19. Published April…
-
Nature publication presents new ‘Blueprint’ revealed how SARS-CoV-2 virus hijacks human cells
On Apr. 30, 2020, an international team of more than 120 scientists has detailed the impact of 75…
-
Emory University launched study on COVID-19 immune responses
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
-
InBios obtained BARDA funding to develop point-of-care COVID-19 test
On Apr. 30, 2020, InBios announced that it had been awarded a contract from the Biomedical Advanced Research…
-
Medigen Vaccine Biologics SARS-CoV-2 qPCR kit obtained CE Marking and Taiwan MOHW’s approval of specific medical device’s manufacturing
On Apr. 30, 2020, Medigen Vaccine Biologics (MVB) complied with EU CE requirements, completed the EU declaration of…
-
Evotec Biologics announced collaboration with Ology Bioservices on antibodies against Coronavirus
On Apr. 30, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics hasd entered into a…
